Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Melatonin modulation of presynaptic nicotinic acetylcholine receptors in the rat vas deferens

Autor: Markus, Rp, Zago, Wm, Regina Carneiro

Publikováno v: Scopus-Elsevier
ResearcherID

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::26e6d8fb762e7462fecc0a2357662e5e
http://www.scopus.com/inward/record.url?eid=2-s2.0-0030426262&partnerID=MN8TOARS

A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data.

Autor: Pagano G; Roche Pharma Research and Early Development (pRED), Neuroscience and Rare Diseases Discovery and Translational Area, Roche Innovation Center, F. Hoffmann-La Roche Ltd., Basel, Switzerland., Boess FG; Roche Pharma Research and Early Development (pRED), Neuroscience and Rare Diseases Discovery and Translational Area, Roche Innovation Center, F. Hoffmann-La Roche Ltd., Basel, Switzerland., Taylor KI; Roche Pharma Research and Early Development (pRED), Neuroscience and Rare Diseases Discovery and Translational Area, Roche Innovation Center, F. Hoffmann-La Roche Ltd., Basel, Switzerland.; Faculty of Psychology, University of Basel, Basel, Switzerland., Ricci B; Roche Pharma Research and Early Development (pRED), Pharmaceutical Sciences, Roche Innovation Center, F. Hoffmann-La Roche Ltd., Basel, Switzerland., Mollenhauer B; Paracelsus-Elena-Klinik, Kassel, Germany.; Department of Neurology, University Medical Center Göttingen, Göttingen, Germany., Poewe W; Department of Neurology, Innsbruck Medical University, Innsbruck, Austria., Boulay A; Idorisa Pharmaceuticals Ltd., Allschwil, Switzerland., Anzures-Cabrera J; Roche Products Ltd., Welwyn Garden City, United Kingdom., Vogt A; Roche Pharma Research and Early Development (pRED), Neuroscience and Rare Diseases Discovery and Translational Area, Roche Innovation Center, F. Hoffmann-La Roche Ltd., Basel, Switzerland., Marchesi M; Roche Pharma Research and Early Development (pRED), Pharmaceutical Sciences, Roche Innovation Center, F. Hoffmann-La Roche Ltd., Basel, Switzerland., Post A; Feetme SAS, Paris, France., Nikolcheva T; F. Hoffmann-La Roche Ltd., Basel, Switzerland., Kinney GG; Prothena Biosciences Inc., South San Francisco, CA, United States., Zago WM; Prothena Biosciences Inc., South San Francisco, CA, United States., Ness DK; Prothena Biosciences Inc., South San Francisco, CA, United States., Svoboda H; Roche Pharma Research and Early Development (pRED), Neuroscience and Rare Diseases Discovery and Translational Area, Roche Innovation Center, F. Hoffmann-La Roche Ltd., Basel, Switzerland., Britschgi M; Roche Pharma Research and Early Development (pRED), Neuroscience and Rare Diseases Discovery and Translational Area, Roche Innovation Center, F. Hoffmann-La Roche Ltd., Basel, Switzerland., Ostrowitzki S; F. Hoffmann-La Roche Ltd., Basel, Switzerland., Simuni T; Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL, United States., Marek K; Institute for Neurodegenerative Disorders, New Haven, CT, United States., Koller M; Prothena Biosciences Inc., South San Francisco, CA, United States., Sevigny J; Prevail Therapeutics, New York, NY, United States., Doody R; F. Hoffmann-La Roche Ltd., Basel, Switzerland., Fontoura P; F. Hoffmann-La Roche Ltd., Basel, Switzerland., Umbricht D; Roche Pharma Research and Early Development (pRED), Neuroscience and Rare Diseases Discovery and Translational Area, Roche Innovation Center, F. Hoffmann-La Roche Ltd., Basel, Switzerland., Bonni A; Roche Pharma Research and Early Development (pRED), Neuroscience and Rare Diseases Discovery and Translational Area, Roche Innovation Center, F. Hoffmann-La Roche Ltd., Basel, Switzerland.

Publikováno v: Frontiers in neurology [Front Neurol] 2021 Oct 01; Vol. 12, pp. 705407. Date of Electronic Publication: 2021 Oct 01 (Print Publication: 2021).

Takusan: a large gene family that regulates synaptic activity.

Autor: Tu S; Center for Neuroscience and Aging, Burnham Institute for Medical Research, La Jolla, CA 92037, USA., Shin Y, Zago WM, States BA, Eroshkin A, Lipton SA, Tong GG, Nakanishi N

Publikováno v: Neuron [Neuron] 2007 Jul 05; Vol. 55 (1), pp. 69-85.

BDNF up-regulates alpha7 nicotinic acetylcholine receptor levels on subpopulations of hippocampal interneurons.

Autor: Massey KA; Neurobiology Section, Division of Biological Sciences, 0357, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0357, USA. kamassey@ucsd.edu, Zago WM, Berg DK

Publikováno v: Molecular and cellular neurosciences [Mol Cell Neurosci] 2006 Dec; Vol. 33 (4), pp. 381-8. Date of Electronic Publication: 2006 Oct 09.